New

Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

ETF screener
JDOC
US46654Q7658
Active ETFEquity

JDOC ETF · JPMorgan Healthcare Leaders ETF

The JDOC Exchange Traded Fund (ETF) is provided by J.P. Morgan Asset Management. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofGlobal Blended Cap1M perf.+7.69%
Last price
$55.16
1M perf.
-1.18%
1M flows
+€1.2M
AuM
€9.4M
E/R
0.65%
Rating
Not rated
ESG Consensus®
esg grade icon
JDOC
$55.16

Performance & flows

Segment for quartile rank
February 2, 2026 → May 1, 2026
0-10-8-6-4-20246%MARAPRMAYMARAPRMAY
Create a free account to view the flows graph
JDOC
$55.21
-6.65%
Global Blended Cap
+3.24%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-1.18%
icon
-6.65%
icon
+9.37%
icon
N/AN/A
-0.74%
-0.50%
-4.56%
icon
Flows

Key fund info

Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) · 
Main characteristics
CUSIP
46654Q765
ISIN
US46654Q7658
AuM
€9.4M
icon
E/R
0.65%
icon
ESG Consensus®
esg grade icon
icon
More details
NAV
5/1/2026
$55.21
1D NAV change
-0.74%
Dividend policy
No. of holdings
61
Inception date
11/1/2023
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Company
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Asset class
Factors
N/A
Investment strategy
The Fund seeks to provide long-term capital appreciation.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
New to Trackinsight?
For individual investors

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors

Trackinsight
Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trial
More professional services:ETF Data ServicesDue Diligence Services

Similar ETFs in your region

XDG3
1M perf.
-0.99%
E/R
0.35%
WEL9
1M perf.
-0.18%
E/R
0.18%
CHCL.B
1M perf.
-4.03%
E/R
0.37%
WHEA
1M perf.
-2.01%
E/R
0.3%
XDWH
1M perf.
+1.26%
E/R
0.25%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
-6.65%
icon
+9.37%
icon
N/A
N/A
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
72.64%
United Kingdom
5.66%
Switzerland
5.09%
Ireland
3.06%
Denmark
2.87%
Japan
2.79%
Belgium
2.14%
Netherlands
2.06%
Germany
2.04%
Other
1.66%
Sectors
Health Care
91.04%
Unavailable
8.93%
Diversification
Total weight of top 15 holdings out of 61
Top 15 holdings
Data as of March 31, 2026
JOHNSON&JOHNSON
ABBVIE
LILLY
MERCK & CO INC
ASTRAZENECA
UNITEDHEALTH GRP
BRISTOL-MYERS SQUIBB
MEDTRONIC PLC
Create a free account to view top holdings
CH1499059983
DANAHER
EDWARDS LIFESCIENCES
BOSTON SCIENTIFIC
REGENERON PHARMACEUTICALS
CVS HEALTH CORP
MCKESSON
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Issuer

J.P. Morgan Asset Management
J.P. Morgan Asset Management ID Card
Number of funds
280
Total AuM
€310.26B
Expense ratio range
0.02% - 1.9053%
Average expense ratio
0.3133%
Top 5 funds by J.P. Morgan Asset Management
AuM
JEPI
JPMorgan Equity Premium Income ETF€38.47B
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF€32.09B
JPST
JPMorgan Ultra-Short Income ETF€32.06B
BBJP
JPMorgan BetaBuilders Japan ETF€14.04B
JCPB
JPMorgan Core Plus Bond ETF€9.86B

J.P. Morgan Asset Management is a global leader in investment management. J.P. Morgan Asset Management's clients include institutions, retail investors and high net worth individuals in every major market throughout the world. J.P. Morgan Asset Management offers global investment management in equities, fixed income, real estate, hedge funds, private equity and liquidity. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorgan Chase had $3.8 trillion in assets and $290.0 billion in stockholders’ equity as of September 30, 2021. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world’s most prominent corporate, institutional and government clients globally.

Via Offical website

Frequently asked questions about JDOC

What does JPMorgan Healthcare Leaders ETF, JDOC, invest in?

JDOC is a Active ETF. This ETF provides exposure to Other Global Health Care Equities.

What is the Total Expense ratio (TER) of JDOC?

JDOC carries a total expense ratio (TER) of 0.65%, indicating the annual cost for holding the fund.

When was JDOC launched?

JDOC was introduced to the market on November 1, 2023. It trades on United States

Who is the ETF issuer of JDOC?

JPMorgan Healthcare Leaders ETF, JDOC, is provided by J.P. Morgan Asset Management. Learn more about J.P. Morgan Asset Management here.

What is the current assets under management (AUM) of JDOC?

JDOC oversees €9.4M in assets as of May 1, 2026.

How has JDOC performed lately?

Based on data from May 1, 2026, JDOC returned -1.18% over the past month, -6.65% over the last three months and -4.56% year-to-date.

What are the latest inflows or outflows for JDOC?

As of May 1, 2026, JDOC recorded net flows of +€1.2M over the last month and +€2.4M year-to-date.

Does JDOC distribute dividends?

JDOC follows a distributing dividend policy, meaning it pays out income to investors. As of May 1, 2026, its 12-month trailing yield was 0.93%.

What are the main country or region exposures of JDOC?

As of March 31, 2026, JDOC has significant geographic allocations in USA, United Kingdom and Switzerland.

In which sector or theme does JDOC invest in?

As of March 31, 2026, JDOC focuses largely on Health Care.

How many securities does JDOC hold and how diversified is it?

As of March 31, 2026, JDOC holds 61 positions in its portfolio, with 59.93% of assets concentrated in its top 15 holdings.

What are the main positions in JDOC?

As of March 31, 2026, JDOC top three holdings include JOHNSON&JOHNSON, ABBVIE and LILLY.

What is the base currency of JDOC?

The base currency of JDOC is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight